vs
ALAMO GROUP INC（ALG）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
ALAMO GROUP INC的季度营收约是Ultragenyx Pharmaceutical Inc.的1.8倍（$373.6M vs $207.3M），ALAMO GROUP INC净利率更高（4.2% vs -62.0%，领先66.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -3.0%），ALAMO GROUP INC自由现金流更多（$69.9M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs -6.3%）
Alamo Drafthouse Cinema是1997年在美国得克萨斯州奥斯汀成立的连锁影院品牌，主打观影期间提供餐食与饮品服务，同时严格要求观众遵守观影礼仪，2024年6月该连锁品牌被索尼影视体验部门收购。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
ALG vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $373.6M | $207.3M |
| 净利润 | $15.5M | $-128.6M |
| 毛利率 | 22.7% | — |
| 营业利润率 | 6.0% | -54.7% |
| 净利率 | 4.2% | -62.0% |
| 营收同比 | -3.0% | 25.9% |
| 净利润同比 | -44.8% | 3.5% |
| 每股收益（稀释后） | $1.28 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $373.6M | $207.3M | ||
| Q3 25 | $420.0M | $159.9M | ||
| Q2 25 | $419.1M | $166.5M | ||
| Q1 25 | $390.9M | $139.3M | ||
| Q4 24 | $385.3M | $164.6M | ||
| Q3 24 | $401.3M | $139.5M | ||
| Q2 24 | $416.3M | $147.0M | ||
| Q1 24 | $425.6M | $108.8M |
| Q4 25 | $15.5M | $-128.6M | ||
| Q3 25 | $25.4M | $-180.4M | ||
| Q2 25 | $31.1M | $-115.0M | ||
| Q1 25 | $31.8M | $-151.1M | ||
| Q4 24 | $28.1M | $-133.2M | ||
| Q3 24 | $27.4M | $-133.5M | ||
| Q2 24 | $28.3M | $-131.6M | ||
| Q1 24 | $32.1M | $-170.7M |
| Q4 25 | 22.7% | — | ||
| Q3 25 | 24.2% | — | ||
| Q2 25 | 25.8% | — | ||
| Q1 25 | 26.3% | — | ||
| Q4 24 | 23.8% | — | ||
| Q3 24 | 25.1% | — | ||
| Q2 24 | 26.0% | — | ||
| Q1 24 | 26.2% | — |
| Q4 25 | 6.0% | -54.7% | ||
| Q3 25 | 8.9% | -106.9% | ||
| Q2 25 | 11.2% | -64.8% | ||
| Q1 25 | 11.4% | -102.6% | ||
| Q4 24 | 8.9% | -74.3% | ||
| Q3 24 | 10.0% | -94.6% | ||
| Q2 24 | 10.4% | -79.1% | ||
| Q1 24 | 11.0% | -151.9% |
| Q4 25 | 4.2% | -62.0% | ||
| Q3 25 | 6.0% | -112.8% | ||
| Q2 25 | 7.4% | -69.0% | ||
| Q1 25 | 8.1% | -108.5% | ||
| Q4 24 | 7.3% | -80.9% | ||
| Q3 24 | 6.8% | -95.7% | ||
| Q2 24 | 6.8% | -89.5% | ||
| Q1 24 | 7.5% | -156.8% |
| Q4 25 | $1.28 | $-1.28 | ||
| Q3 25 | $2.10 | $-1.81 | ||
| Q2 25 | $2.57 | $-1.17 | ||
| Q1 25 | $2.64 | $-1.57 | ||
| Q4 24 | $2.33 | $-1.34 | ||
| Q3 24 | $2.28 | $-1.40 | ||
| Q2 24 | $2.35 | $-1.52 | ||
| Q1 24 | $2.67 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $309.7M | $421.0M |
| 总债务越低越好 | $190.7M | — |
| 股东权益账面价值 | $1.1B | $-80.0M |
| 总资产 | $1.6B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.17× | — |
8季度趋势，按日历期对齐
| Q4 25 | $309.7M | $421.0M | ||
| Q3 25 | $244.8M | $202.5M | ||
| Q2 25 | $201.8M | $176.3M | ||
| Q1 25 | $200.3M | $127.1M | ||
| Q4 24 | $197.3M | $174.0M | ||
| Q3 24 | $140.0M | $150.6M | ||
| Q2 24 | $118.5M | $480.7M | ||
| Q1 24 | $121.8M | $112.3M |
| Q4 25 | $190.7M | — | ||
| Q3 25 | $194.4M | — | ||
| Q2 25 | $198.1M | — | ||
| Q1 25 | $201.8M | — | ||
| Q4 24 | $205.5M | — | ||
| Q3 24 | $209.2M | — | ||
| Q2 24 | $278.6M | — | ||
| Q1 24 | $306.5M | — |
| Q4 25 | $1.1B | $-80.0M | ||
| Q3 25 | $1.1B | $9.2M | ||
| Q2 25 | $1.1B | $151.3M | ||
| Q1 25 | $1.1B | $144.2M | ||
| Q4 24 | $1.0B | $255.0M | ||
| Q3 24 | $1.0B | $346.8M | ||
| Q2 24 | $979.7M | $432.4M | ||
| Q1 24 | $956.6M | $140.3M |
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.6B | $1.2B | ||
| Q2 25 | $1.6B | $1.3B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.5B | $1.5B | ||
| Q3 24 | $1.5B | $1.5B | ||
| Q2 24 | $1.5B | $1.6B | ||
| Q1 24 | $1.5B | $1.3B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.17× | — | ||
| Q2 25 | 0.18× | — | ||
| Q1 25 | 0.19× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.21× | — | ||
| Q2 24 | 0.28× | — | ||
| Q1 24 | 0.32× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $75.1M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $69.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | 18.7% | -48.6% |
| 资本支出强度资本支出/营收 | 1.4% | 0.5% |
| 现金转化率经营现金流/净利润 | 4.84× | — |
| 过去12个月自由现金流最近4个季度 | $146.9M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $75.1M | $-99.8M | ||
| Q3 25 | $65.5M | $-91.4M | ||
| Q2 25 | $22.7M | $-108.3M | ||
| Q1 25 | $14.2M | $-166.5M | ||
| Q4 24 | $79.1M | $-79.3M | ||
| Q3 24 | $96.3M | $-67.0M | ||
| Q2 24 | $33.2M | $-77.0M | ||
| Q1 24 | $1.1M | $-190.7M |
| Q4 25 | $69.9M | $-100.8M | ||
| Q3 25 | $53.1M | $-92.7M | ||
| Q2 25 | $15.7M | $-110.7M | ||
| Q1 25 | $8.2M | $-167.8M | ||
| Q4 24 | $73.1M | $-79.5M | ||
| Q3 24 | $88.4M | $-68.6M | ||
| Q2 24 | $28.8M | $-79.0M | ||
| Q1 24 | $-5.5M | $-193.9M |
| Q4 25 | 18.7% | -48.6% | ||
| Q3 25 | 12.6% | -58.0% | ||
| Q2 25 | 3.8% | -66.5% | ||
| Q1 25 | 2.1% | -120.5% | ||
| Q4 24 | 19.0% | -48.3% | ||
| Q3 24 | 22.0% | -49.2% | ||
| Q2 24 | 6.9% | -53.7% | ||
| Q1 24 | -1.3% | -178.2% |
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 3.0% | 0.8% | ||
| Q2 25 | 1.7% | 1.5% | ||
| Q1 25 | 1.5% | 1.0% | ||
| Q4 24 | 1.6% | 0.1% | ||
| Q3 24 | 2.0% | 1.2% | ||
| Q2 24 | 1.1% | 1.4% | ||
| Q1 24 | 1.6% | 3.0% |
| Q4 25 | 4.84× | — | ||
| Q3 25 | 2.58× | — | ||
| Q2 25 | 0.73× | — | ||
| Q1 25 | 0.45× | — | ||
| Q4 24 | 2.82× | — | ||
| Q3 24 | 3.51× | — | ||
| Q2 24 | 1.17× | — | ||
| Q1 24 | 0.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALG
| Wholegood Units | $293.2M | 78% |
| Parts | $61.6M | 16% |
| Other Revenue | $18.9M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
